Therefore, CBX8, c-Myc and cyclin A2 are most likely not good therapeutic targets; however, they are able to promote proliferation even while their inhibition may enhance metastasis, indicating that current strategies mainly targeting proliferation may have undesirable effects on tumor progression. This evidence concerns the gene CCNA2 and neoplasm.